Stock Analysis

High Growth Tech Stocks To Watch In September 2024

NasdaqGS:BGNE
Source: Shutterstock

The market has climbed 2.6% in the last 7 days and is up 31% over the last 12 months, with earnings forecast to grow by 15% annually. In this thriving environment, identifying high-growth tech stocks that align with these robust conditions can be crucial for investors looking to capitalize on future opportunities.

Top 10 High Growth Tech Companies In The United States

NameRevenue GrowthEarnings GrowthGrowth Rating
TG Therapeutics28.39%43.54%★★★★★★
Super Micro Computer20.81%27.98%★★★★★★
Sarepta Therapeutics23.58%44.12%★★★★★★
Invivyd42.91%70.39%★★★★★★
Ardelyx27.46%66.34%★★★★★★
Amicus Therapeutics20.32%62.37%★★★★★★
Clene71.89%60.05%★★★★★★
Travere Therapeutics26.68%68.80%★★★★★★
Seagen22.57%71.80%★★★★★★
ImmunoGen26.00%45.85%★★★★★★

Click here to see the full list of 248 stocks from our US High Growth Tech and AI Stocks screener.

Below we spotlight a couple of our favorites from our exclusive screener.

BeiGene (NasdaqGS:BGNE)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: BeiGene, Ltd. is an oncology company focused on discovering and developing cancer treatments for patients globally, with a market cap of $20.97 billion.

Operations: BeiGene, Ltd. engages in the discovery and development of cancer treatments, generating $3.10 billion from pharmaceutical products across the United States, China, Europe, and other international markets.

BeiGene, navigating through a challenging landscape with a net loss reduction from $729.57 million to $371.56 million year-over-year, is showing signs of resilience despite being unprofitable. The company's R&D commitment is evident in its substantial investment in TEVIMBRA®, which has been approved across multiple regions for various cancer treatments, highlighting its strategic focus on global oncology leadership. With an expected revenue growth of 19.3% per annum outpacing the US market average of 8.7%, BeiGene's strategy to expand into lucrative markets and enhance its product offerings through rigorous trials could position it favorably for future profitability, forecasted to materialize within three years with earnings potentially growing by 64.1% annually.

NasdaqGS:BGNE Earnings and Revenue Growth as at Sep 2024
NasdaqGS:BGNE Earnings and Revenue Growth as at Sep 2024

Lumentum Holdings (NasdaqGS:LITE)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Lumentum Holdings Inc. manufactures and sells optical and photonic products across the Americas, the Asia-Pacific, Europe, the Middle East, and Africa with a market cap of $3.96 billion.

Operations: Lumentum Holdings Inc. generates revenue primarily from its Industrial Tech ($274.30 million) and Cloud & Networking ($1.08 billion) segments, focusing on optical and photonic products across multiple regions. The company's gross profit margin is a key financial metric to consider when evaluating its performance in these markets.

Lumentum Holdings, grappling with a challenging fiscal year that saw revenues shrink to $1.36 billion from $1.77 billion, signals a strategic pivot with its robust R&D investments aimed at reversing recent downturns. Despite a net loss widening to $546.5 million, the company's forward-looking guidance anticipates revenue between $315 million and $335 million for Q1 2025, reflecting potential stabilization. Notably, Lumentum's commitment to innovation is underscored by an expected surge in earnings growth by 114.4% annually and revenue growth projected at 16.9% per year—both metrics outpacing the broader U.S market trends.

NasdaqGS:LITE Revenue and Expenses Breakdown as at Sep 2024
NasdaqGS:LITE Revenue and Expenses Breakdown as at Sep 2024

Tripadvisor (NasdaqGS:TRIP)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Tripadvisor, Inc. operates as an online travel company providing travel guidance products and services worldwide, with a market cap of approximately $1.95 billion (NasdaqGS:TRIP).

Operations: Tripadvisor generates revenue through its segments: Viator ($791 million), Thefork ($164 million), and Brand Tripadvisor ($998 million). The company has a market cap of approximately $1.95 billion.

Tripadvisor, transitioning into profitability this year, reflects a strategic shift with its R&D investments aligning closely with industry innovation trends. With a 6.1% expected annual revenue growth and a remarkable 38.6% forecast in earnings growth, the company is setting a robust pace against the broader U.S market's average. Recent initiatives like the 'Destination: Space' platform underscore its commitment to diversifying offerings and enhancing user engagement, potentially setting the stage for sustained long-term growth despite current market challenges marked by modest quarterly revenue projections and share repurchases totaling $49.94 million this year.

NasdaqGS:TRIP Revenue and Expenses Breakdown as at Sep 2024
NasdaqGS:TRIP Revenue and Expenses Breakdown as at Sep 2024

Where To Now?

Searching for a Fresh Perspective?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Valuation is complex, but we're here to simplify it.

Discover if BeiGene might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com